Intravenous MSC Therapy on Ischemia-Reperfusion Injury in Patients With Myocardial Infarction
Status:
Not yet recruiting
Trial end date:
2025-12-30
Target enrollment:
Participant gender:
Summary
The investigators scheduled to assess the value of intravenous injection of WJ-MSC in
patients with ST-segment elevation myocardial infarction (STEMI).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School